Literature DB >> 12939223

Deficiency of gelatinase a suppresses smooth muscle cell invasion and development of experimental intimal hyperplasia.

Masafumi Kuzuya1, Shigeru Kanda, Takeshi Sasaki, Norika Tamaya-Mori, Xian Wu Cheng, Takeshi Itoh, Shigeyoshi Itohara, Akihisa Iguchi.   

Abstract

BACKGROUND: Although it has been demonstrated that matrix metalloproteinases (MMPs) play an important role in the arterial remodeling in atherosclerosis and restenosis, it is not clear which MMP is involved in which process. To define the role of MMP-2 in arterial remodeling, we evaluated the influence of the targeted deletion of the MMP-2 gene on vascular remodeling after flow cessation in the murine carotid arteries. METHODS AND
RESULTS: The left common carotid arteries of wild-type and MMP-2-deficient mice were ligated just proximal to their bifurcations, and the animals were then processed for morphological and biochemical studies at specific time points. MMP-2 activity and mRNA levels increased in ligated carotid arteries of wild-type mice on the basis of observation by gelatin zymography and quantitative real-time RT-PCR. There was significantly less intimal hyperplasia in MMP-2-deficient mice at 2 and 4 weeks after ligation than there in wild-type mice. Arterial explants from the aorta of MMP-2-deficient mice showed that smooth muscle cell (SMC) migration was inhibited in comparison with wild-type mice. The chemoattractant-directed invasion through a reconstituted basement membrane barrier was significantly reduced in cultured SMCs derived from MMP-2-deficient mice, although no difference was observed in SMC migration across the filter or in proliferative response between the control and MMP-2-deficient mice.
CONCLUSIONS: In a mouse carotid artery blood flow cessation model, MMP-2 contributes to intimal hyperplasia mainly through the SMC migration from the media into the intima by degrading and breaching the extracellular matrix proteins surrounding each cell and the internal elastic lamina.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12939223     DOI: 10.1161/01.CIR.0000086463.15540.3C

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  42 in total

Review 1.  Matrix metalloproteinases promote arterial remodeling in aging, hypertension, and atherosclerosis.

Authors:  Mingyi Wang; Soo Hyuk Kim; Robert E Monticone; Edward G Lakatta
Journal:  Hypertension       Date:  2015-02-09       Impact factor: 10.190

2.  Localization of cysteine protease, cathepsin S, to the surface of vascular smooth muscle cells by association with integrin alphanubeta3.

Authors:  Xian Wu Cheng; Masafumi Kuzuya; Kae Nakamura; Qun Di; Zexuan Liu; Takeshi Sasaki; Shigeru Kanda; Hai Jin; Guo-Ping Shi; Toyoaki Murohara; Mitsuhiro Yokota; Akihisa Iguchi
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

Review 3.  MMPs as therapeutic targets--still a viable option?

Authors:  Barbara Fingleton
Journal:  Semin Cell Dev Biol       Date:  2007-07-06       Impact factor: 7.727

4.  Altered vascular remodeling in fibulin-5-deficient mice reveals a role of fibulin-5 in smooth muscle cell proliferation and migration.

Authors:  Jeffrey A Spencer; Shelby L Hacker; Elaine C Davis; Robert P Mecham; Russ H Knutsen; Dean Y Li; Robert D Gerard; James A Richardson; Eric N Olson; Hiromi Yanagisawa
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

5.  MT1-MMP-dependent remodeling of cardiac extracellular matrix structure and function following myocardial infarction.

Authors:  Gerald C Koenig; R Grant Rowe; Sharlene M Day; Farideh Sabeh; Jeffrey J Atkinson; Kenneth R Cooke; Stephen J Weiss
Journal:  Am J Pathol       Date:  2012-03-29       Impact factor: 4.307

6.  Bioreducible crosslinked polyelectrolyte complexes for MMP-2 siRNA delivery into human vascular smooth muscle cells.

Authors:  Dokyoung Lee; Dongkyu Kim; Hyejung Mok; Ji Hoon Jeong; Donghoon Choi; Sun Hwa Kim
Journal:  Pharm Res       Date:  2012-04-04       Impact factor: 4.200

7.  Intronic regulation of matrix metalloproteinase-2 revealed by in vivo transcriptional analysis in ischemia.

Authors:  Jackie G Lee; Sia Dahi; Rajeev Mahimkar; Nathaniel L Tulloch; Maria A Alfonso-Jaume; David H Lovett; Rajabrata Sarkar
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-28       Impact factor: 11.205

8.  SM22alpha-targeted deletion of bone morphogenetic protein receptor 1A in mice impairs cardiac and vascular development, and influences organogenesis.

Authors:  Nesrine El-Bizri; Christophe Guignabert; Lingli Wang; Alexander Cheng; Kryn Stankunas; Ching-Pin Chang; Yuji Mishina; Marlene Rabinovitch
Journal:  Development       Date:  2008-07-30       Impact factor: 6.868

9.  The effect of matrix metalloproteinase 2 and matrix metalloproteinase 2/9 deletion in experimental post-thrombotic vein wall remodeling.

Authors:  Kristopher B Deatrick; Catherine E Luke; Megan A Elfline; Vikram Sood; Joseph Baldwin; Gilbert R Upchurch; Farouc A Jaffer; Thomas W Wakefield; Peter K Henke
Journal:  J Vasc Surg       Date:  2013-03-13       Impact factor: 4.268

10.  TLR3 deficiency protects against collagen degradation and medial destruction in murine atherosclerotic plaques.

Authors:  Minako Ishibashi; Scott Sayers; Jeanine M D'Armiento; Alan R Tall; Carrie L Welch
Journal:  Atherosclerosis       Date:  2013-04-09       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.